RMA Long Island IVF

Melville, New York 11747

Medical Director: Beth McAvey, MD

RMA Long Island IVF, located in Melville, New York, offers comprehensive fertility care under the guidance of Medical Director Beth McAvey, MD. The clinic provides a full range of services including IVF, egg freezing, donor egg programs, and surrogacy support to help you build your family. With a verified lab accreditation, you can trust that your treatment takes place in a facility that meets the highest standards of care.

Understanding success rates can help you feel more informed about your journey ahead. For patients under 35, RMA Long Island IVF reports a live birth rate of 44.30%, while patients ages 35-37 have a live birth rate of 32.10%. The clinic's experience shows through their volume—they performed 2,242 treatment cycles in 2022, reflecting their commitment to helping many families achieve their dreams of parenthood. When you're navigating fertility treatment, having a team with both expertise and experience can provide the reassurance you need during this important chapter of your life.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3544.30%-4.144.80%48.4%
35–3732.10%-3.945.80%36%
38–4019.80%-3.838.60%23.6%
Over 406.00%-3.521.50%9.5%

Based on 2,242 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.